Oculis’ eye drops for diabetic macular edema flunk Phase 3 test

June 1, 2026 02:58 AM EDT R&D Oculis’ eye drops for di­a­bet­ic mac­u­lar ede­ma flunk Phase 3 test Reynald Castaneda Deputy Editor Oculis saw its stock plum­met af­ter re­port­ing that its in­ves­ti­ga­tion­al eye drops for di­a­bet­ic mac­u­lar ede­ma (DME) did not suc­ceed in a pair of Phase … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER